194 related articles for article (PubMed ID: 37852632)
1. Biomimetic Nanocarriers of Pro-Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis.
Anghelache M; Voicu G; Deleanu M; Turtoi M; Safciuc F; Anton R; Boteanu D; Fenyo IM; Manduteanu I; Simionescu M; Calin M
Adv Healthc Mater; 2024 Jan; 13(3):e2302238. PubMed ID: 37852632
[TBL] [Abstract][Full Text] [Related]
2. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
3. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.
Satish M; Agrawal DK
Expert Rev Cardiovasc Ther; 2019 Mar; 17(3):177-184. PubMed ID: 30582389
[TBL] [Abstract][Full Text] [Related]
4. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.
Díaz Del Campo LS; Rodrigues-Díez R; Salaices M; Briones AM; García-Redondo AB
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408952
[TBL] [Abstract][Full Text] [Related]
5. Specialized pro-resolving mediators in cardiovascular diseases.
Fredman G; Spite M
Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
Kotlyarov S; Kotlyarova A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
[TBL] [Abstract][Full Text] [Related]
7. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease.
Spite M; Fredman G
Adv Pharmacol; 2023; 97():257-281. PubMed ID: 37236761
[TBL] [Abstract][Full Text] [Related]
8. Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators.
Perez-Hernandez J; Chiurchiù V; Perruche S; You S
Front Immunol; 2021; 12():768133. PubMed ID: 34868025
[TBL] [Abstract][Full Text] [Related]
9. Pro-resolution therapeutics for cardiovascular diseases.
Heinz J; Marinello M; Fredman G
Prostaglandins Other Lipid Mediat; 2017 Sep; 132():12-16. PubMed ID: 28450270
[TBL] [Abstract][Full Text] [Related]
10. Specialized pro-resolving mediator network: an update on production and actions.
Chiang N; Serhan CN
Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
[TBL] [Abstract][Full Text] [Related]
11. The role of non-resolving inflammation in atherosclerosis.
Kasikara C; Doran AC; Cai B; Tabas I
J Clin Invest; 2018 Jul; 128(7):2713-2723. PubMed ID: 30108191
[TBL] [Abstract][Full Text] [Related]
12. Specialized pro-resolving lipid mediators in endodontics: a narrative review.
Aubeux D; Peters OA; Hosseinpour S; Tessier S; Geoffroy V; Pérez F; Gaudin A
BMC Oral Health; 2021 May; 21(1):276. PubMed ID: 34030680
[TBL] [Abstract][Full Text] [Related]
13. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
[TBL] [Abstract][Full Text] [Related]
14. PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs).
Regidor PA; de la Rosa X; Müller A; Mayr M; Gonzalez Santos F; Gracia Banzo R; Rizo JM
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203665
[TBL] [Abstract][Full Text] [Related]
15. Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins.
Barnig C; Lutzweiler G; Giannini M; Lejay A; Charles AL; Meyer A; Geny B
Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740110
[TBL] [Abstract][Full Text] [Related]
16. Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch.
Ji RR
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():273-293. PubMed ID: 36100219
[TBL] [Abstract][Full Text] [Related]
17. Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
Fredman G
Front Pharmacol; 2019; 10():205. PubMed ID: 30899222
[TBL] [Abstract][Full Text] [Related]
18. The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation.
Sousa AB; Barbosa JN
J Funct Biomater; 2023 Apr; 14(4):. PubMed ID: 37103313
[TBL] [Abstract][Full Text] [Related]
19. Pro-resolving lipid mediators: Agents of anti-ageing?
Doyle R; Sadlier DM; Godson C
Semin Immunol; 2018 Dec; 40():36-48. PubMed ID: 30293857
[TBL] [Abstract][Full Text] [Related]
20. G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives.
Mastromarino M; Lacivita E; Colabufo NA; Leopoldo M
Mini Rev Med Chem; 2020; 20(20):2090-2103. PubMed ID: 32682373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
